Endovascular Engineering Funding: $137M Raised, Series C
Endovascular Engineering is based in California. It has raised $137M in total funding. Latest round: Series C. Backed by 415 Capital, S3 Ventures, SANTÉ.
Endovascular Engineering funding overview
Endovascular Engineering is based in California. Endovascular Engineering has raised $137M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in April 2026. The round record for Endovascular Engineering runs through 2026; nothing later has been disclosed. Investors on record include 415 Capital, S3 Ventures, SANTÉ, Panakes Partners, M&L Healthcare. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Endovascular Engineering funding
How much has Endovascular Engineering raised?
Endovascular Engineering has raised $137M in total disclosed funding across the rounds on record.
Who has invested in Endovascular Engineering?
415 Capital, S3 Ventures, SANTÉ, Panakes Partners, M&L Healthcare are named among the investors backing Endovascular Engineering.
What was the latest Endovascular Engineering funding round?
The most recent disclosed round is a Series C, announced in April 2026.
Where is Endovascular Engineering based?
Endovascular Engineering is based in California.
When did Endovascular Engineering last raise?
The last disclosed Endovascular Engineering round closed in April 2026 at Series C.
Round data for Endovascular Engineering is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in California and backer lists below.
Companies related to Endovascular Engineering (21)
